Burning Stock Performance

BNR
 Stock
  

USD 3.89  0.40  11.46%   

On a scale of 0 to 100, Burning Rock holds a performance score of 6. The firm shows a Beta (market volatility) of -0.1557, which signifies not very significant fluctuations relative to the market. Let's try to break down what Burning's beta means in this case. As returns on the market increase, returns on owning Burning Rock are expected to decrease at a much lower rate. During the bear market, Burning Rock is likely to outperform the market. Although it is vital to follow Burning Rock Biotech historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-eight technical indicators for Burning Rock Biotech, which you can use to evaluate the performance of the firm. Please makes use of Burning Rock Biotech maximum drawdown, as well as the relationship between the expected short fall and rate of daily change to make a quick decision on whether Burning Rock price patterns will revert.
  
Burning Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Burning Rock Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Burning Rock reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Last Split Factor
1:3
Last Split Date
2014-08-01

Burning Price Channel

Quick Ratio3.69
Fifty Two Week Low1.7400
Target High Price14.18
Fifty Two Week High22.8300
Target Low Price6.70

Burning Rock Relative Risk vs. Return Landscape

If you would invest  316.00  in Burning Rock Biotech on May 14, 2022 and sell it today you would earn a total of  73.00  from holding Burning Rock Biotech or generate 23.1% return on investment over 90 days. Burning Rock Biotech is generating 0.5259% of daily returns assuming volatility of 6.244% on return distribution over 90 days investment horizon. In other words, 54% of stocks are less volatile than Burning, and above 90% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Burning Rock is expected to generate 4.91 times more return on investment than the market. However, the company is 4.91 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The DOW is currently generating roughly 0.07 per unit of risk.

Burning Rock Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Burning Rock's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Burning Rock Biotech, and traders can use it to determine the average amount a Burning Rock's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0842

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsBNR
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 6.24
  actual daily
 
 54 %
of total potential
 
5454
Expected Return
 0.53
  actual daily
 
 10 %
of total potential
 
1010
Risk-Adjusted Return
 0.08
  actual daily
 
 6 %
of total potential
 
66
Based on monthly moving average Burning Rock is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Burning Rock by adding it to a well-diversified portfolio.

About Burning Rock Performance

To evaluate Burning Rock Biotech Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Burning Rock generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Burning Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Burning Rock Biotech stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Burning's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-37 M-39.9 M
Return on Average Assets(0.32) (0.35) 
Return on Average Equity(0.38) (0.41) 
Return on Invested Capital(1.56) (1.68) 
Return on Sales(1.56) (1.61) 
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the Peoples Republic of China. The company was incorporated in 2014 and is headquartered in Guangzhou, China. Burning Rock operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1394 people.

Things to note about Burning Rock Biotech

Checking the ongoing alerts about Burning Rock for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Burning Rock Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Burning Rock Alerts

Equity Alerts and Improvement Suggestions

Burning Rock Biotech is way too risky over 90 days horizon
Burning Rock Biotech appears to be risky and price may revert if volatility continues
Burning Rock Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 536.76 M. Reported Net Loss for the year was (886.67 M) with profit before taxes, overhead, and interest of 364.15 M.
Burning Rock Biotech has about 1.33 B in cash with (509.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from sports.yahoo.com: Burning Rock Biotech shareholders have endured a 84 percent loss from investing in the stock a year ago - Yahoo Sports
Continue to Trending Equities. Note that the Burning Rock Biotech information on this page should be used as a complementary analysis to other Burning Rock's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Burning Stock analysis

When running Burning Rock Biotech price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Is Burning Rock's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Burning Rock. If investors know Burning will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Burning Rock listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
376.6 M
Quarterly Revenue Growth YOY
0.27
Return On Assets
-0.23
Return On Equity
-0.44
The market value of Burning Rock Biotech is measured differently than its book value, which is the value of Burning that is recorded on the company's balance sheet. Investors also form their own opinion of Burning Rock's value that differs from its market value or its book value, called intrinsic value, which is Burning Rock's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Burning Rock's market value can be influenced by many factors that don't directly affect Burning Rock's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Burning Rock's value and its price as these two are different measures arrived at by different means. Investors typically determine Burning Rock value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Burning Rock's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.